Using Diabetes Technology in Hospitalized Patients.

Abstract

There is an estimated 350,000 persons wearing an insulin pump and 2.4 million wearing a continuous glucose monitor (CGM) sensor in the United States. The last few decades have ushered in advancements with the integration of insulin delivery and continuous glucose evaluations which offer a more precise tight insulin delivery and glycemic control. However, when hospital admissions are necessary, most desire to continue to wear their devices. The last several decades and during the pandemic, many agencies such as the Joint Commission, FDA, and diabetes organizations have generated position statements and guidelines to allow the most optimal diabetes treatment, even when hospitalized.